Avaleht › Südamepuudulikkus › Colorado
Südamepuudulikkus kliinilised uuringud osariigis Colorado
23 uuringut haiguse Südamepuudulikkus jaoks otsivad osalejaid osariigis Colorado.
Linnad osariigis Colorado
Ametlik uuringutekst (inglise keeles)
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Aurora
VärbamineFaas 3
Vanused 18–130 · Kõik sood · Uuendatud 2. okt 2026 · NCT06307652A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Univ of Colorado at Denver, Aurora
VärbamineFaas 2
Vanused 40–84 · Kõik sood · Uuendatud 30. sept 2026 · NCT06979362A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Colorado Springs
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Rocky Mountain Regional VA Medical Center, Aurora
VärbamineFaas 3
Vanused 18–85 · Kõik sood · Uuendatud 24. sept 2026 · NCT06736574Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Aurora
- Research Site, Englewood
VärbamineFaas 3
Vanused 40 ja vanemad · Kõik sood · Uuendatud 15. sept 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10001, Aurora, CO, Aurora
- CON-10005, Denver, CO, Denver
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. sept 2026 · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Aurora, CO Investigative Site 10001, Aurora
- Denver, CO Investigative Site 10005, Denver
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. sept 2026 · NCT06008197Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Children's Hospital Colorado ( Site 0012), Aurora
VärbamineFaas 2/3
29 Days – 17 Years · Kõik sood · Uuendatud 28. aug 2026 · NCT05714085Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
- Denver Health and Hospital Authority, Denver
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 26. aug 2026 · NCT07435662Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
- Children's Hospital Colorado, Aurora
VärbamineVaatlusuuring
Kuni 18 aastane · Kõik sood · Uuendatud 25. aug 2026 · NCT06532890Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Aurora
- Centennial
- Colorado Springs
- ja veel 1
VärbamineVaatlusuuring
Kõik vanused · Kõik sood · Uuendatud 20. aug 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- UC Denver, AMC, Aurora
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 19. aug 2026 · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Univ of Colorado at Denver, Aurora
- VA Eastern Colorado Health Care System, Aurora
- Intermountain Heart & Vascular, Denver
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 18. aug 2026 · NCT07567001Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- University of Colorado, Aurora
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. juuli 2026 · NCT06526988A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10110, Aurora, CO, Aurora
- FIN-10001, Aurora, CO, Aurora
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. juuli 2026 · NCT06033950A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Hospital Colorado - Anschutz Medical Campus - Cardiology, Aurora
VärbamineFaas 3
Kuni 18 aastane · Kõik sood · Uuendatud 29. juuni 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Hospital Colorado - Anschutz Medical Campus - Cardiology, Aurora
VärbamineFaas 3
6 Months – 17 Years · Kõik sood · Uuendatud 15. juuni 2026 · NCT07188805The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- South Denver Cardiology, Littleton
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. apr 2026 · NCT03142152Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
- Boulder Heart, Boulder
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. apr 2026 · NCT07224906Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Barbara Davis Center / University of Colorado Denver, Aurora
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 24. märts 2026 · NCT06217302Left vs Left Randomized Clinical Trial
- University of Colorado (Anschutz Medical Campus), Denver
- South Denver Cardiology Associates, Littleton
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2025 · NCT05650658Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- University of Colorado - Anschutz Medical Campus, Aurora
VärbamineFaas 1
Vanused 18–65 · Kõik sood · Uuendatud 6. veebr 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- University of Colorado, Denver, Aurora
VärbamineVaatlusuuring
Vanused 14–65 · Kõik sood · Uuendatud 1. nov 2024 · NCT06311708Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.